(Updated)

Malaysia inked deals with Covax, Pfizer, AstraZeneca to cover 40% of population. Govt also in talks with Sinovac, CanSino, Gamaleya to increase vaccine supply to 80% of population

Malaysia inked deals with Covax, Pfizer, AstraZeneca to cover 40% of population. Govt also in talks with Sinovac, CanSino, Gamaleya to increase vaccine supply to 80% of population
-A +A

Malaysia inked deals with Covax, Pfizer, AstraZeneca to cover 40% of the population. Govt also in talks with Sinovac, CanSino, Gamaleya to increase vaccine supply to 80% of the population.

For the full story, read Phase 3 clinical study of Covid-19 vaccine from China to begin on Jan 21 in nine hospitals, says PM.